Sign up to save your podcastsEmail addressPasswordRegisterOrContinue with GoogleAlready have an account? Log in here.
"Got Knowledge Doc" Podkast with Dr. RR BaligaThe "Got Knowledge Doc" Podkast, hosted by Dr. Ragavendra R. Baliga, is a knowledge-driven platform designed for physicians and healthcare providers see... more
FAQs about Dr RR Baliga's "Got Knowledge Doc" Podkast:How many episodes does Dr RR Baliga's "Got Knowledge Doc" Podkast have?The podcast currently has 1,026 episodes available.
May 10, 2025Lower Blood Pressure, Sharper Minds, Less Dementia, Longer Lives 🧠💊🌾🧠 Big win for brains & blood pressure! In a massive rural China trial (n=33,995), lowering BP with non-physician care ↓ dementia risk by 15%! A scalable, lifesaving model for LMICs. 🌾💊📉 #Dementia #Hypertension #GlobalHealth...more4minPlay
May 10, 2025🌬️ Breathe Easy: Nasal Vaccines to the Rescue!🚀🌬️ Nasal vaccines: A breath of fresh air in respiratory infection prevention! 🌟 Boosts mucosal immunity (SIgA & IgG) 💪, reduces transmission 🌡️, and protects against COVID-19, influenza, RSV, and more! #Vaccines #PublicHealth #Innovation 🦠💉...more4minPlay
May 09, 2025🧬 Silencing Risk: Lepodisiran vs Lp(a)🚨 New hope for high Lp(a)! 💉 Lepodisiran, a long-acting siRNA, slashed Lp(a) by 94% with just 2 shots/year. 🔬 RNA precision meets cardiac prevention. 📉 Silent killer, silenced. #CardioTwitter #RNAtherapy #LipoproteinA...more5minPlay
May 09, 2025💨 Breathing Battles: Navigating COPD Phenotypes🌬️🚶♂️ COPD comes in many forms! From chronic bronchitis 🪫 to emphysema 💨, frequent exacerbators 🚨, asthma-COPD overlap 🌪️, and eosinophilic type 🧫. Tailoring treatment to phenotype is key! #COPD #PrecisionMedicine #RespiratoryCare...more5minPlay
May 08, 2025💊 TANDEM Triumph: Dual Power for LDL Cholesterol Reduction!🚀 TANDEM Trial: Combining Obicetrapib & Ezetimibe for a powerful LDL reduction! 💊 ✅ -48.6% vs placebo, -27.9% vs Ezetimibe, -16.8% vs Obicetrapib 💪 Safe, effective, and oral! #Cardiology #LipidManagement #ASCVD...more5minPlay
May 08, 2025Fungal Pharmacists, Fatty Liver, Future Frontiers 🧬🩸🍄A gut fungus 🍄 (Fusarium foetens) secretes FF-C1 🧪, a metabolite that inhibits CerS6 and lowers ceramides 🩸—shielding mice from MASH 🛡️. Fungi aren't just freeloaders—they may be our next therapeutic allies! 💊🧠 #Microbiome #LiverHealth #FungalTherapy #Science...more5minPlay
May 07, 2025💪 Powerful Cholesterol Control: Obicetrapib in the Spotlight 🌟🚀 Obicetrapib: A Breakthrough in LDL Lowering! 📉 Reduced LDL by 29.9% in high-risk patients (p 💡 Promising adjunct to lipid-lowering therapy! #Cardiology #LipidManagement #HeartHealth 💓...more3minPlay
May 07, 2025Fat Chance! 🔬🧬 Middle-Age Spread Starts at the Cellular LevelHere's a tweet with emojis based on the article: 🧬 Middle-age spread decoded! 🕰️ Visceral fat grows in midlife not from bigger cells—but new ones! 🎯 CP-A cells fire up fat formation via LIFR–STAT3 🔥 💊 Targeting them may halt metabolic disease before it starts. #Aging #Obesity #CellBiology #Metabolism 🧫 Would you like a version with a more humorous tone or one tailored for clinicians?...more4minPlay
May 06, 2025🔍📊🛡️ Detect, Decode, Defend: A New Era in Coronary Risk Prediction🚨 New era in heart disease prediction! 🧬 + 🧪 + 🤖 = Meta-prediction model that beats PCE & QRISK3 📈 Detects hidden CAD risk in young, women & "low-risk" groups 🎯 Precision prevention just got personal. 🫀 Published in Nature Medicine #CardioTwitter #AI #Genomics #CAD...more4minPlay
May 06, 2025Dr RR Baliga's Philosophical Discourses: Epicurus (Greece, 341–270 BCE) – Founder of EpicureanismEpicurus (341–270 BC) was an ancient Greek philosopher who founded Epicureanism, emphasizing the pursuit of a tranquil, happy life through ataraxia (freedom from fear) and aponia (absence of pain). His teachings combined atomism, ethics, and naturalistic theology, advocating simple living, friendship, and the rejection of superstition....more4minPlay
FAQs about Dr RR Baliga's "Got Knowledge Doc" Podkast:How many episodes does Dr RR Baliga's "Got Knowledge Doc" Podkast have?The podcast currently has 1,026 episodes available.